Suken A. Shah, M.D., a renown pediatric orthopedic surgeon and Division Chief of the Nemours Spine and Scoliosis Center at Nemours Children’s Hospital in Wilmington, Delaware, has been elected to the 2021-2022 Scoliosis Research Society (SRS) Board of Directors. Dr. Shah will continue to serve as the SRS Education Council Chair.
Suken A. Shah, M.D. Named to Scoliosis Research Society Board
A 20-year veteran of the field, Dr. Shah is respected for his innovations, research, and clinical work. Also Clinical Fellowship Director for the orthopedics department at Nemours Children’s, Dr. Shah trains residents, fellows, and visiting observers in advanced spinal deformity correction.
“I am honored to represent Nemours Children’s Health on the SRS Board,” says Dr. Shah. “I look forward to lending my skills and expertise, alongside other international leaders, to help in the continuing advancement of scoliosis research, education, and pediatric care.”
Describing what laid the groundwork for this new position, Dr. Shah told OTW, “I had the opportunity to serve on the board as a member at large several years ago and have chaired many committees on the Educational Council, including the Program Committee and Education Committee, so I had firsthand knowledge of the responsibilities and workflow of the various committees on the council. The Council Chair serves as an advisor to the committee chairs and as a liaison to the Board and the Presidential Line, so this prior committee experience is very valuable.”
“Planning for 2022 has already begun. We have the IMAST in April and the Annual Meeting in September, so various committees like IMAST, Program, Education, CME (Continuing Medical Education) and Blended Learning are already hard at work to fulfill our educational mission. We will also plan several webinars for both members and patients and their families. But, at the forefront is to offer best in class education on scoliosis and other spinal disorders to learners live at our meetings and those who attend virtually.”
Execute and Measure
Dr. Shah continued, “How we deliver that content and how we measure our effectiveness by enhancing care of all patients with spinal deformities and improved outcomes will be key in the new normal as we thrive as an international professional society devoted to patients with spinal deformities and those who care for them. We are fortunate to have very passionate members, leaders, and staff who work hard to serve the society and its mission, and I am confident we will exceed our expectations of this ambitious agenda.”

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.